Calithera to Participate in Jefferies Virtual Healthcare Conference and SVB Leerink Oncology 1×1 Day

NEXT STORY
New Data Show Importance of Vectra® Testing and Biomarkers in Predicting Risk for Cardiovascular Events in Patients with Rheumatoid Arthritis
PREV STORY
BioXcel Therapeutics Announces Completion of Pre-NDA Meeting with FDA for BXCL501 for the Acute Treatment of Agitation in Patients with Schizophrenia and Bipolar Disorders
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Helsinn Group and Glenmark Pharmaceuticals enter into an exclusive licensing agreement for launch of AKYNZEO® in India and Nepal

author_avatar
NASDAQ Market News

Genmab Announces Data to be Presented at SITC 35th Anniversary Annual Meeting

author_avatar
NASDAQ Market News

Isothermal Nucleic Acid Amplification Technology (INAAT) Market Analysis, Trends, and Forecasts, 2019-2025 – Market to Witness Healthy Growth, Driven by Low-cost Advantages

author_avatar
NASDAQ Market News